About this document
Hepatitis C Drug Pipeline Overview by Ahmed Kamel is a document available to read on EtoBox.
The document provides an overview of hepatitis C treatments currently in clinical development, including direct-acting antivirals in phases 1, 2 and 3 of clinical trials. It lists the drug name, category, company and phase for each treatment. For some drugs in phases 2 and 3, it provides brief comments summarizing key trial results, such as high rates of viral suppression or sustained virologic response. The document is intended to help readers understand and track the progress of new hepatitis C treatments
- Author
- Ahmed Kamel
- Language
- EN